Paper42231920
The acetylation mechanism and engineering strategy of isocitrate lyase for optimizing biosynthesis in Escherichia coli.
Jia R and 6 others. Synth Syst Biotechnol, 2026. Cited by 0 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The acetylation mechanism and engineering strategy of isocitrate lyase for optimizing biosynthesis in Escherichia coli. Papers, record 42231920. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42231920
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The acetylation mechanism and engineering strategy of isocitrate lyase for optimizing biosynthesis in Escherichia coli.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25,417,765 | The E. coli sirtuin CobB shows no preference for enzymatic and nonenzymatic lysine acetylation substrate sites. | Microbiologyopen | 2015 | https://conductscience.org/library/papers/25417765 | PubMed |
| 2 | 30,102,971 | Engineering an in vivo EP-bifido pathway in Escherichia coli for high-yield acetyl-CoA generation with low CO2 emission. | Metab Eng | 2019 | https://conductscience.org/library/papers/30102971 | PubMed |
| 3 | 34,624,455 | Bacterial protein acetylation and its role in cellular physiology and metabolic regulation. | Biotechnol Adv | 2021 | https://conductscience.org/library/papers/34624455 | PubMed |
| 4 | 16,738,554 | Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection. | Mol Syst Biol | 2006 | https://conductscience.org/library/papers/16738554 | PubMed |
| 5 | 27,832,787 | The effect of protein acetylation on the formation and processing of inclusion bodies and endogenous protein aggregates in Escherichia coli cells. | Microb Cell Fact | 2016 | https://conductscience.org/library/papers/27832787 | PubMed |
| 6 | 29,592,804 | Metabolic engineering of a xylose pathway for biotechnological production of glycolate in Escherichia coli. | Microb Cell Fact | 2018 | https://conductscience.org/library/papers/29592804 | PubMed |
| 7 | 27,484,197 | Reversible lysine acetylation is involved in DNA replication initiation by regulating activities of initiator DnaA in Escherichia coli. | Sci Rep | 2016 | https://conductscience.org/library/papers/27484197 | PubMed |
| 8 | 23,358,999 | Directed evolution of phloroglucinol synthase PhlD with increased stability for phloroglucinol production. | Appl Microbiol Biotechnol | 2013 | https://conductscience.org/library/papers/23358999 | PubMed |
| 9 | 28,462,789 | Protein Acetylation and Its Role in Bacterial Virulence. | Trends Microbiol | 2017 | https://conductscience.org/library/papers/28462789 | PubMed |
| 10 | 34,340,775 | Posttranslational modifications in systems biology. | Adv Protein Chem Struct Biol | 2021 | https://conductscience.org/library/papers/34340775 | PubMed |
| 11 | 11,526,312 | The structure and domain organization of Escherichia coli isocitrate lyase. | Acta Crystallogr D Biol Crystallogr | 2001 | https://conductscience.org/library/papers/11526312 | PubMed |
| 12 | 13,943,142 | The presence of acetyl groups of histones. | Biochem J | 1963 | https://conductscience.org/library/papers/13943142 | PubMed |
| 13 | 26,716,769 | YcgC represents a new protein deacetylase family in prokaryotes. | Elife | 2015 | https://conductscience.org/library/papers/26716769 | PubMed |
| 14 | 28,679,637 | Mechanism-based inactivator of isocitrate lyases 1 and 2 from Mycobacterium tuberculosis. | Proc Natl Acad Sci U S A | 2017 | https://conductscience.org/library/papers/28679637 | PubMed |
| 15 | 26,179,745 | Acylation of Biomolecules in Prokaryotes: a Widespread Strategy for the Control of Biological Function and Metabolic Stress. | Microbiol Mol Biol Rev | 2015 | https://conductscience.org/library/papers/26179745 | PubMed |
| 16 | 29,477,857 | Balancing the carbon flux distributions between the TCA cycle and glyoxylate shunt to produce glycolate at high yield and titer in Escherichia coli. | Metab Eng | 2018 | https://conductscience.org/library/papers/29477857 | PubMed |
| 17 | 23,523,103 | Lysine-5 acetylation negatively regulates lactate dehydrogenase A and is decreased in pancreatic cancer. | Cancer Cell | 2013 | https://conductscience.org/library/papers/23523103 | PubMed |
| 18 | 30,782,634 | Global Lysine Acetylation in Escherichia coli Results from Growth Conditions That Favor Acetate Fermentation. | J Bacteriol | 2019 | https://conductscience.org/library/papers/30782634 | PubMed |
| 19 | 21,643,705 | Improved phloroglucinol production by metabolically engineered Escherichia coli. | Appl Microbiol Biotechnol | 2011 | https://conductscience.org/library/papers/21643705 | PubMed |
| 20 | 23,686,280 | How to achieve high-level expression of microbial enzymes: strategies and perspectives. | Bioengineered | 2013 | https://conductscience.org/library/papers/23686280 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42231920
GET https://conductscience.org/api/papers/v1/42231920/references?page=2